Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a Healthcare company (Biotechnology) with a market capitalization of $2.1B. The Maz Rating grades it against the other companies in its sector.
Maravai LifeSciences Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $7.28, Maravai LifeSciences Holdings, Inc. trades at 9.7x sales and 5.5x book value. Over the last twelve months it generated about $213M of revenue and a net loss of $127M. It runs a gross margin of 38.9%, an operating margin of -18.8% and a net margin of -30.8%. It shows return on equity of -31.9%, return on invested capital of -7.0% and a free cash flow yield of -0.6%. On the balance sheet: a debt-to-equity ratio of 1.15 and a current ratio of 4.66. Over the past 52 weeks the share price ranged from $2.80 to $9.42, with a beta of 0.63.
Maravai LifeSciences Holdings, Inc. does not currently pay a dividend.
14 Wall Street analyst ratings cover the stock: 8 Buy, 5 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.